BETHESDA, Md., USA: The National Institutes of Health has granted $2 million to a collaborative research project at the University of Bristol, U.K. The funds will be used to gain new insights into the role of Candida albicans in periodontal diseases.
The research project led by Prof. Howard Jenkinson, Head of Research at the School of Oral and Dental Sciences, has been funded by the NIH since 2006. The renewed funding allows for this project to be extended for another five years to continue the investigation into the mechanisms by which these microbes cause infections and into better ways to control them.
Previous studies by Jenkinson and his team have shown that C. albicans interacts very closely with several different types of bacteria in the human body, which help it colonize and stimulate the production of hyphae.
Jenkinson said that one of their new ventures is to better understand the role of C. albicans in periodontal gum and jaw disease. There is evidence that C. albicans may be involved together with bacteria in eroding bone, causing teeth to fall out. While the focus of this work is oral disease, the research will also consider Candida infections in other parts of the body.
C. albicans is the species of the yeast that causes the most infections. According to Jenkinson, these microorganisms cause thrush, denture sore mouth, and often fatal infections in hospital. Over 50 percent of the population have suffered from yeast infections at one time or another.
C. albicans is thus a major concern in public health, according to him. "They are quite resilient to antimicrobial agents. Once Candida are growing in the body, they are difficult to clear. Therefore, one of our research goals is to find new ways of blocking the ability of Candida to colonize humans," he said.
Howard Jenkinson has been a professor and Oral Microbiology chair at the University of Bristol since 1997. For 25 years, he has been researching the adhesion, colonization and virulence properties of human oral microorganisms and Candida in particular.
According to Robert Dwayne Lunsford, director of the NIH Microbiology Program, Jenkinson is regarded as a world authority on streptococcal adhesions, virulence, and molecular biology and was extremely productive during his initial five-year project.
"Looking to the future, the C. albicans dynamic is worth pursuing because it has the potential for discovery of new therapeutic modalities to prevent oral colonization and ultimately systemic disease since the oral cavity can often serve as a reservoir of this fungal pathogen," he said.
BUFFALO, N.Y., USA: The Department of Oral Biology in the University at Buffalo School of Dental Medicine has been awarded a National Institutes of Health ...
Dental professionals pursuing groundbreaking dental implant research may be eligible for as much as $30,000 in research grants. The Academy of ...
Recipients of the 2016-2017 Osseointegration Foundation (OF) Research Grants were announced at the Academy of Osseointegration’s 2016 Annual Meeting ...
LOUISVILLE, KY, USA: University of Louisville researchers are a step closer to eliminating periodontal disease through their work to develop synthetic ...
CLEVELAND, OH, USA: Studying how the mouth wards off diseases will have implications for understanding overall how people stay healthy. The Case Western ...
The Osseointegration Foundation is now accepting applications for the 2020-2021 AO/OF Research Grant.
CHICAGO, Ill., US: The American Academy of Periodontology (AAP) recently announced that members Hsun Liang Chan, DDS, MS, and Jeff C.W. Wang, DDS, DMSc, are...
CHICAGO, Ill., USA: Screenings by dentists for the most common chronic medical diseases could save the American health care system as much as $102.6 million...
NEW YORK, NY, USA: Thanks to the generosity of Trident chewing gum, National Children’s Oral Health Foundation: America’s Toothfairy (NCOHF) ...
CHICAGO, Ill., USA: The American Association of Endodontists and the AAE Foundation are seeking applications to support research to investigate regenerative...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
To post a reply please login or register